| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
|
Hepatology
|
2001
|
1.29
|
|
2
|
On the mechanism of fibrin-specific plasminogen activation by staphylokinase.
|
J Biol Chem
|
1991
|
1.04
|
|
3
|
Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
|
Thromb Haemost
|
1999
|
0.99
|
|
4
|
Laparoscope-assisted anal sphincter-preserving operation preceded by transanal procedure.
|
Tech Coloproctol
|
2006
|
0.96
|
|
5
|
Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis.
|
J Thromb Haemost
|
2007
|
0.90
|
|
6
|
Induction of rat liver bilirubin-conjugating enzymes and glutathione S-transferase by rifampicin.
|
Gastroenterol Jpn
|
1985
|
0.87
|
|
7
|
Plasminogen activator inhibitor 1 in human carcinoma tissues.
|
Int J Cancer
|
1991
|
0.86
|
|
8
|
Endothelin A-receptor blockade worsens endotoxin-induced hepatic microcirculatory changes and necrosis.
|
Gastroenterology
|
1998
|
0.85
|
|
9
|
Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
|
Int J Clin Pharmacol Ther
|
2008
|
0.85
|
|
10
|
Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines.
|
Clin Chim Acta
|
2000
|
0.84
|
|
11
|
Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression.
|
Biochem Biophys Res Commun
|
1999
|
0.83
|
|
12
|
Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage.
|
Clin Exp Pharmacol Physiol
|
1997
|
0.83
|
|
13
|
A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.
|
J Thromb Haemost
|
2007
|
0.82
|
|
14
|
Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice.
|
Thromb Haemost
|
2011
|
0.82
|
|
15
|
Plasminogen is essential for granulation tissue formation during the recovery process after liver injury in mice.
|
J Thromb Haemost
|
2010
|
0.82
|
|
16
|
Vagus nerve is involved in lack of blood reflow into sinusoids after rat hepatic ischemia.
|
Am J Physiol Heart Circ Physiol
|
2000
|
0.80
|
|
17
|
Thrombolytic properties of staphylokinase.
|
Blood
|
1990
|
0.80
|
|
18
|
Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
|
J Thromb Haemost
|
2003
|
0.80
|
|
19
|
tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor.
|
J Cardiovasc Pharmacol
|
2000
|
0.79
|
|
20
|
The role of the pericellular fibrinolytic system in angiogenesis.
|
Jpn J Physiol
|
1997
|
0.79
|
|
21
|
Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
|
Blood Coagul Fibrinolysis
|
2000
|
0.79
|
|
22
|
Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo.
|
Thromb Haemost
|
2012
|
0.79
|
|
23
|
Roles of urokinase type plasminogen activator in a brain stab wound.
|
Brain Res
|
2000
|
0.78
|
|
24
|
Recovery of blood flow and oxygen transport after temporary ischemia of rat liver.
|
Am J Physiol
|
1998
|
0.78
|
|
25
|
Lack of tPA significantly affects antithrombotic therapy by a GPIIb/IIIa antagonist, but not by a thrombin inhibitor in mice.
|
Thromb Haemost
|
2000
|
0.77
|
|
26
|
Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
|
Am J Hematol
|
1996
|
0.77
|
|
27
|
Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.
|
Biochim Biophys Acta
|
1997
|
0.77
|
|
28
|
Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
|
Thromb Haemost
|
1996
|
0.77
|
|
29
|
Effect of bone resorbing factors on u-PA and its specific receptor in osteosarcoma cell line.
|
Clin Chim Acta
|
1993
|
0.77
|
|
30
|
Production and characterization of single-chain tissue-type plasminogen activator produced by an established cell line from human uterine muscle.
|
Cell Struct Funct
|
1989
|
0.76
|
|
31
|
The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.
|
Br J Pharmacol
|
2000
|
0.75
|
|
32
|
Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
|
Thromb Res
|
1992
|
0.75
|
|
33
|
Molecular analysis of urinary AT III related antigen in liver cirrhosis.
|
Life Sci
|
1986
|
0.75
|
|
34
|
Enhancement of tissue-type plasminogen activator (t-PA)-mediated plasminogen activation on the surface of endothelial cells by t-PA receptor.
|
Blood Coagul Fibrinolysis
|
2001
|
0.75
|
|
35
|
Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.
|
Life Sci
|
1995
|
0.75
|
|
36
|
Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient mice.
|
Neurosci Lett
|
1999
|
0.75
|
|
37
|
Regulation of scu-PA secretion and u-PA receptor expression in osteoblast-like cells.
|
Cell Struct Funct
|
1993
|
0.75
|
|
38
|
Cerebral plasminogen activator activity in spontaneously hypertensive stroke-prone rats.
|
Stroke
|
1992
|
0.75
|
|
39
|
Urokinase-type plasminogen activator and its specific receptor in high metastatic and non-metastatic cell lines derived from human lung adenocarcinoma.
|
Thromb Res
|
1992
|
0.75
|
|
40
|
Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line.
|
Biochim Biophys Acta
|
1995
|
0.75
|
|
41
|
Impurity of thrombin preparations for clinical use.
|
J Clin Hosp Pharm
|
1985
|
0.75
|
|
42
|
[Structural study of staphylokinase related with the expression of activity].
|
Rinsho Byori
|
1997
|
0.75
|
|
43
|
Comparative studies of thrombolysis with single-chain and two-chain recombinant tissue-type plasminogen activators in canine coronary thrombosis.
|
J Cardiovasc Pharmacol
|
1996
|
0.75
|
|
44
|
A hereditary dysfibrinogenemia: fibrinogen Awaji.
|
Haemostasis
|
1987
|
0.75
|
|
45
|
Identification of urokinase-type plasminogen activator receptor in human endothelial cells and its modulation by phorbol myristate acetate.
|
Cell Struct Funct
|
1995
|
0.75
|
|
46
|
Fibrinolytic activity in liver tissues of stroke-prone spontaneously hypertensive rats.
|
Clin Exp Pharmacol Physiol Suppl
|
1995
|
0.75
|
|
47
|
Effects of lipopolysaccharide on the expression of fibrinolytic factors in an established cell line from human endothelial cells.
|
Life Sci
|
1996
|
0.75
|
|
48
|
[Development of new thrombolytic enzymes by gene technology--with special references to t-PA, scu-PA, protein C].
|
Nihon Rinsho
|
1989
|
0.75
|
|
49
|
Assay method for single-chain urokinase-type plasminogen activator.
|
Hematol Pathol
|
1989
|
0.75
|
|
50
|
Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.
|
Thromb Res Suppl
|
1990
|
0.75
|
|
51
|
Effect of Na+, K+ ion concentration on the production of plasminogen activator from a melanoma cell line.
|
Thromb Res
|
1985
|
0.75
|
|
52
|
Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix.
|
Life Sci
|
2000
|
0.75
|
|
53
|
Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
|
Thromb Res Suppl
|
1990
|
0.75
|
|
54
|
Effect of monensin on secretion of t-PA from melanoma (Bowes).
|
Cell Struct Funct
|
1989
|
0.75
|
|
55
|
Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.
|
Thromb Res
|
1994
|
0.75
|
|
56
|
Enhanced urokinase-type plasminogen activator activity by extracellular matrix protein obtained from highly metastatic human lung adenocarcinoma cell line.
|
Clin Chim Acta
|
1996
|
0.75
|
|
57
|
Synthetic dipeptide, N-stearoyl-D-Ser-L-Pro-OEt, induces release of tissue-type plasminogen activator in cultured cells and in experimental animals.
|
Chem Pharm Bull (Tokyo)
|
1994
|
0.75
|
|
58
|
New aspects of fibrinolytic proteins in brain development.
|
Cell Struct Funct
|
1997
|
0.75
|
|
59
|
Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
|
Blood Coagul Fibrinolysis
|
1992
|
0.75
|
|
60
|
Monoclonal antibody interferes with fibrin binding of t-PA.
|
Thromb Res
|
1988
|
0.75
|
|
61
|
Plasminogen activator inhibitor in stomach and colorectal carcinomas.
|
Semin Thromb Hemost
|
1991
|
0.75
|
|
62
|
Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase.
|
Arch Biochem Biophys
|
2001
|
0.75
|
|
63
|
Transcriptional regulation of urokinase-type plasminogen activator receptor by cyclic AMP in PL-21 human myeloid leukemia cells: comparison with the regulation by phorbol myristate acetate.
|
Thromb Haemost
|
1998
|
0.75
|
|
64
|
A case of Helicobacter pylori infection complicated with gastric cancer, gastric mucosa-associated lymphoid tissue lymphoma, and idiopathic thrombocytopenic purpura successfully treated with laparoscopy-assisted total gastrectomy and splenectomy.
|
Asian J Endosc Surg
|
2011
|
0.75
|
|
65
|
A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue-type plasminogen activator.
|
J Thromb Haemost
|
2011
|
0.75
|
|
66
|
[Lung resection for lung carcinoma with idiopathic interstitial pneumonia].
|
Nihon Kyobu Geka Gakkai Zasshi
|
1994
|
0.75
|
|
67
|
Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
|
Thromb Haemost
|
1994
|
0.75
|
|
68
|
[MR imaging of bladder tumors using fluid attenuated inversion recovery (FLAIR) technique].
|
Hinyokika Kiyo
|
1996
|
0.75
|
|
69
|
Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis.
|
Thromb Res
|
1988
|
0.75
|
|
70
|
New type of plasminogen activator produced by an established cell line from human ovary.
|
Thromb Res Suppl
|
1988
|
0.75
|
|
71
|
Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
|
Thromb Res
|
1994
|
0.75
|
|
72
|
Monoclonal antibody enhances plasminogen activation by t-PA.
|
Thromb Res
|
1989
|
0.75
|
|
73
|
Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domain.
|
Thromb Haemost
|
1992
|
0.75
|